Jacobi Medical Center

Futó vizsgálatok

• Toboroz

  Study of GS-0415 and How It Works in People With HIV

  NCT07719491· 1. fázis· Gilead Sciences· Forrás

• Toboroz

  Study of the Pharmacokinetics and Safety of Glecaprevir/Pibrentasvir Initiated in Pregnancy in Women With Hepatitis C With and Without HIV

  NCT07040319· 1/2. fázis· National Institute of Allergy and Infectious Diseases (NIAID)· Forrás

• Toboroz

  Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)

  NCT07224360· 2. fázis· CSL Behring· Forrás

• Toboroz

  Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

  NCT06909565· 4. fázis· Duke University· Forrás

• Toboroz

  Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis

  NCT06699849· 2. fázis· CSL Behring· Forrás

• Toboroz

  A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

  NCT06612268· 3. fázis· Novo Nordisk A/S· Forrás

• Toboroz

  A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia

  NCT06609226· 3. fázis· Novo Nordisk A/S· Forrás

• Meghívásos bevonás

  Real-world Effectiveness of HPV Vaccine in Women Living With HIV and Its Impact on Cervical Cancer Screening Accuracies

  NCT06144229· University of California, Los Angeles· Forrás

• Fut, nem toboroz

  Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes

  NCT06334133· 3. fázis· vTv Therapeutics· Forrás

• Fut, nem toboroz

  Diagnostic Performance of Small RNA Blood Test in Patients Undergoing Follow-up Imaging After Positive Low Dose CT Screening for Cancer of the Lung

  NCT05987189· Hummingbird Diagnostics· Forrás

• Toboroz

  A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD

  NCT05431088· 2/3. fázis· Pfizer· Forrás

• Fut, nem toboroz

  Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease

  NCT05099770· 3. fázis· Prokidney· Forrás

• Fut, nem toboroz

  Study Evaluating the Safety and Efficacy of Islatravir in Combination With Lenacapavir in Virologically Suppressed People With HIV

  NCT05052996· 2. fázis· Gilead Sciences· Forrás

• Fut, nem toboroz

  A Study of Etavopivat in Adults and Adolescents With Sickle Cell Disease (HIBISCUS)

  NCT04624659· 3. fázis· Forma Therapeutics, Inc.· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Sarlósejtes vérszegénység4 toboroz
• HIV-fertőzés3 toboroz
• Familiáris hiperkoleszterinémia1 toboroz
• Hepatitis C1 toboroz
• Koszorúér-betegség1 toboroz
• Méhnyakrák1 toboroz

Lezárt vizsgálatok

• Leállították

  Open-Label Extension Study to Pioneer Study 6058-SCD-101

  NCT07401823· 2. fázis· Fulcrum Therapeutics· Forrás

• Lezárult

  Pharmacokinetics, Pharmacodynamics and Safety of Epeleuton in Patients With Sickle Cell Disease

  NCT05861453· 2. fázis· Afimmune· Forrás

• Lezárult

  Research Study Investigating How Well NDec Works in People With Sickle Cell Disease

  NCT05405114· 2. fázis· Novo Nordisk A/S· Forrás

• Leállították

  A Study to Evaluate the Long-term Safety of Inclacumab Administered to Participants With Sickle Cell Disease

  NCT05348915· 3. fázis· Pfizer· Forrás

• Lezárult

  Adherence Connection for Counseling, Education, and Support (ACCESS) II

  NCT04499781· NYU Langone Health· Forrás

• Lezárult

  Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Pociredir

  NCT05169580· 1. fázis· Fulcrum Therapeutics· Forrás

• Leállították

  A Study of a Single Dose of Inclacumab to Reduce Re-admission in Participants With Sickle Cell Disease and Recurrent Vaso-occlusive Crises

  NCT04927247· 3. fázis· Pfizer· Forrás

• Lezárult

  A Study of Guselkumab and Golimumab Combination Therapy in Participants With Active Psoriatic Arthritis

  NCT05071664· 2. fázis· Janssen Research & Development, LLC· Forrás

• Lezárult

  A Study to Assess the Safety and Efficacy of Inclacumab in Participants With Sickle Cell Disease Experiencing Vaso-occlusive Crises

  NCT04935879· 3. fázis· Pfizer· Forrás

• Lezárult

  Adolescent Master Protocol for Participants 18 Years of Age and Older (AMP Up)

  NCT02119702· Harvard School of Public Health (HSPH)· Forrás

• Lezárult

  Surveillance Monitoring for ART Toxicities Study in HIV Uninfected Children Born to HIV Infected Women

  NCT01310023· Harvard School of Public Health (HSPH)· Forrás

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Krónikus limfoid leukémia (CLL)11 munka · 0 vizsgálat
• Sarlósejtes vérszegénység9 munka · 13 vizsgálat
• Köpenysejtes limfóma8 munka · 0 vizsgálat
• Magas vérnyomás6 munka · 0 vizsgálat